ConductScience.org, home

Paper5725875

Choline-deficiency fatty liver: impaired release of hepatic triglycerides.

Lombardi B and 2 others. J Lipid Res, 1968. Cited by 132 papers, by iCite.

Cite this record

ConductScience Library. Choline-deficiency fatty liver: impaired release of hepatic triglycerides. Papers, record 5725875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5725875

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Choline-deficiency fatty liver: impaired release of hepatic triglycerides.
PubMed
Journal
J Lipid Res
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
132
iCite
Revised in PubMed
2021-02-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lombardi BB
2Pani PP
3Schlunk FFF F

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Choline DeficiencyMajor topic
Fatty LiverMajor topic
Intestinal MucosaMajor topic
LiverMajor topic
PhospholipidsMajor topic
TriglyceridesMajor topic
Animals
Carbon Isotopes
Choline
Diet
Hyperlipidemias
Male
Microsomes
Palmitic Acids
Rats
Surface-Active Agents
Time Factors
Tritium

Source PubMed

Download CSV of topics

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
42398652Chronic choline restriction remodels hepatic lipid metabolism and drives insulin resistance through a CD36-ETNPPL regulatory axis.Mol Metab2026https://conductscience.org/library/papers/42398652PubMed
39472442Systems biology approaches identify metabolic signatures of dietary lifespan and healthspan across species.Nat Commun2024https://conductscience.org/library/papers/39472442PubMed
39296030Modulation of liver cholesterol homeostasis by choline supplementation during fibrosis resolution.Heliyon2024https://conductscience.org/library/papers/39296030PubMed
38223375Characterization of a model to induce hyperlipidemia in feed-restricted dairy cows.JDS Commun2024https://conductscience.org/library/papers/38223375PubMed
38034347Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma.iScience2023https://conductscience.org/library/papers/38034347PubMed
37100056Integrative genetic analysis identifies FLVCR1 as a plasma-membrane choline transporter in mammals.Cell Metab2023https://conductscience.org/library/papers/37100056PubMed
36689425Serum metabolomic analysis of the dose-response effect of dietary choline in overweight male cats fed at maintenance energy requirements.PLoS One2023https://conductscience.org/library/papers/36689425PubMed
35994501Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice.PLoS One2022https://conductscience.org/library/papers/35994501PubMed
35641141Dose-response relationship between dietary choline and serum lipid profile, energy expenditure, and respiratory quotient in overweight adult cats fed at maintenance energy requirements.J Anim Sci2022https://conductscience.org/library/papers/35641141PubMed
35163026Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.Int J Mol Sci2022https://conductscience.org/library/papers/35163026PubMed
34438654Serum Lipid, Amino Acid and Acylcarnitine Profiles of Obese Cats Supplemented with Dietary Choline and Fed to Maintenance Energy Requirements.Animals (Basel)2021https://conductscience.org/library/papers/34438654PubMed
33182674Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/33182674PubMed
30776907Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.Exp Biol Med (Maywood)2019https://conductscience.org/library/papers/30776907PubMed
30042736Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease.Front Endocrinol (Lausanne)2018https://conductscience.org/library/papers/30042736PubMed
28635586GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.Gene Expr2017https://conductscience.org/library/papers/28635586PubMed
26435097Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.J Card Fail2015https://conductscience.org/library/papers/26435097PubMed
25482527EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.Cell Adh Migr2014https://conductscience.org/library/papers/25482527PubMed
25286440Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury.Gastroenterology2015https://conductscience.org/library/papers/25286440PubMed
25024595Experimental models of non-alcoholic fatty liver disease in rats.World J Gastroenterol2014https://conductscience.org/library/papers/25024595PubMed
23073625S-adenosylmethionine in liver health, injury, and cancer.Physiol Rev2012https://conductscience.org/library/papers/23073625PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5725875

GET https://conductscience.org/api/papers/v1/5725875/cited_by?page=2